Diagnostics for Better care, Everywhere. En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic solutions." title="" class="btn" data-container="body" data-html="true" data-id="228992" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#0077b5" tabindex="0" data-original-title="En Carta Diagnostics"> 882
Activities
Technologies
Entity types
Location
Paris, France
Paris
France
Employees
Scale: 2-10
Estimated: 10
Engaged corporates
5Added in Motherbase
1 year agoDiagnostics for better care, everywhere.
Diagnostics for Better care, Everywhere.
En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic solutions.
synthetic biology, cell-free, biotech, and molecular sensing
Diagnostics for better care, everywhere.
Diagnostics for Better care, Everywhere.
En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic solutions.
En Carta provides low cost and high accuracy paper based diagnostics. Our first product is a SARS-CoV-2 or COVID-19 Diagnostic
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() Linkera Consulting, Information Services | Linkera Consulting, Information Services | Other 31 May 2024 | | |
![]() Région Ile de France National and local authorities, Government Administration | Région Ile de France National and local authorities, Government Administration | Other 23 May 2024 | | |
![]() Paris Biotech Santé Startup accelerator & VC, Civic and Social Organizations | Paris Biotech Santé Startup accelerator & VC, Civic and Social Organizations | Other 25 Dec 2024 | | |
![]() 50 Partners Startup accelerator & VC, Venture Capital & Private Equity | 50 Partners Startup accelerator & VC, Venture Capital & Private Equity | Other 25 Dec 2024 | | |
![]() WILCO Software Development | WILCO Software Development | Other 31 Jul 2022 | |